NEW YORK--(BUSINESS WIRE)--KKR, a leading global investment firm, today announced that credit funds and accounts managed by KKR served as lead investors on a financing to support the growth investment from funds managed by Harvest Partners, LP (“Harvest”) in Med-Metrix, LLC (“Med-Metrix” or “the Company”), a leading provider of technology-enabled Revenue Cycle Management ("RCM") solutions. KKR Capital Markets also served as Left Lead Arranger and Bookrunner on the transaction. The Company's man
Related Questions
Could this investment lead to consolidation or partnership opportunities within the healthcare technology industry?
What are the likely exit strategies for KKR and Harvest Partners, and what timeline is anticipated?
What macro or sector risks could impact the success of this growth investment?
How will the financing affect Med‑Metrix’s valuation and future funding needs?
How does this financing compare to recent capital raises by competitors in the revenue cycle management sector?
Will the involvement of KKR as lead investor and bookrunner signal increased credibility or attract additional investors?
How might this transaction influence Med‑Metrix’s growth trajectory and market share in the RCM technology space?
Are there any covenants or control provisions that could affect management’s strategic flexibility?
What are the specific terms and size of the investment, and how might they impact the company's capital structure?
What potential upside or downside does this deal present for the stock price of Med‑Metrix and related peers?